Cargando…

Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium

Advances in drug research not only depend on high throughput screening to evaluate large numbers of lead compounds but also on the development of in vitro models which can simulate human tissues in terms of drug permeability and functions. Potential failures, such as poor permeability or interaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Patient, Jamie D., Hajiali, Hadi, Harris, Kate, Abrahamsson, Bertil, Tannergren, Christer, White, Lisa J., Ghaemmaghami, Amir M., Williams, Philip M., Roberts, Clive J., Rose, Felicity R. A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524416/
https://www.ncbi.nlm.nih.gov/pubmed/31133850
http://dx.doi.org/10.3389/fphar.2019.00456
_version_ 1783419557568839680
author Patient, Jamie D.
Hajiali, Hadi
Harris, Kate
Abrahamsson, Bertil
Tannergren, Christer
White, Lisa J.
Ghaemmaghami, Amir M.
Williams, Philip M.
Roberts, Clive J.
Rose, Felicity R. A. J.
author_facet Patient, Jamie D.
Hajiali, Hadi
Harris, Kate
Abrahamsson, Bertil
Tannergren, Christer
White, Lisa J.
Ghaemmaghami, Amir M.
Williams, Philip M.
Roberts, Clive J.
Rose, Felicity R. A. J.
author_sort Patient, Jamie D.
collection PubMed
description Advances in drug research not only depend on high throughput screening to evaluate large numbers of lead compounds but also on the development of in vitro models which can simulate human tissues in terms of drug permeability and functions. Potential failures, such as poor permeability or interaction with efflux drug transporters, can be identified in epithelial Caco-2 monolayer models and can impact a drug candidate’s progression onto the next stages of the drug development process. Whilst monolayer models demonstrate reasonably good prediction of in vivo permeability for some compounds, more developed in vitro tools are needed to assess new entities that enable closer in vivo in vitro correlation. In this study, an in vitro model of the human intestinal epithelium was developed by utilizing nanofibers, fabricated using electrospinning, to mimic the structure of the basement membrane. We assessed Caco-2 cell response to these materials and investigated the physiological properties of these cells cultured on the fibrous supports, focusing on barrier integrity and drug-permeability properties. The obtained data illustrate that 2D Caco-2 Transwell(®) cultures exhibit artificially high trans-epithelial electrical resistance (TEER) compared to cells cultured on the 3D nanofibrous scaffolds which show TEER values similar to ex vivo porcine tissue (also measured in this study). Furthermore, our results demonstrate that the 3D nanofibrous scaffolds influence the barrier integrity of the Caco-2 monolayer to confer drug-absorption properties that more closely mimic native gut tissue particularly for studying passive epithelial transport. We propose that this 3D model is a suitable in vitro model for investigating drug absorption and intestinal metabolism.
format Online
Article
Text
id pubmed-6524416
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65244162019-05-27 Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium Patient, Jamie D. Hajiali, Hadi Harris, Kate Abrahamsson, Bertil Tannergren, Christer White, Lisa J. Ghaemmaghami, Amir M. Williams, Philip M. Roberts, Clive J. Rose, Felicity R. A. J. Front Pharmacol Pharmacology Advances in drug research not only depend on high throughput screening to evaluate large numbers of lead compounds but also on the development of in vitro models which can simulate human tissues in terms of drug permeability and functions. Potential failures, such as poor permeability or interaction with efflux drug transporters, can be identified in epithelial Caco-2 monolayer models and can impact a drug candidate’s progression onto the next stages of the drug development process. Whilst monolayer models demonstrate reasonably good prediction of in vivo permeability for some compounds, more developed in vitro tools are needed to assess new entities that enable closer in vivo in vitro correlation. In this study, an in vitro model of the human intestinal epithelium was developed by utilizing nanofibers, fabricated using electrospinning, to mimic the structure of the basement membrane. We assessed Caco-2 cell response to these materials and investigated the physiological properties of these cells cultured on the fibrous supports, focusing on barrier integrity and drug-permeability properties. The obtained data illustrate that 2D Caco-2 Transwell(®) cultures exhibit artificially high trans-epithelial electrical resistance (TEER) compared to cells cultured on the 3D nanofibrous scaffolds which show TEER values similar to ex vivo porcine tissue (also measured in this study). Furthermore, our results demonstrate that the 3D nanofibrous scaffolds influence the barrier integrity of the Caco-2 monolayer to confer drug-absorption properties that more closely mimic native gut tissue particularly for studying passive epithelial transport. We propose that this 3D model is a suitable in vitro model for investigating drug absorption and intestinal metabolism. Frontiers Media S.A. 2019-05-10 /pmc/articles/PMC6524416/ /pubmed/31133850 http://dx.doi.org/10.3389/fphar.2019.00456 Text en Copyright © 2019 Patient, Hajiali, Harris, Abrahamsson, Tannergren, White, Ghaemmaghami, Williams, Roberts and Rose. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Patient, Jamie D.
Hajiali, Hadi
Harris, Kate
Abrahamsson, Bertil
Tannergren, Christer
White, Lisa J.
Ghaemmaghami, Amir M.
Williams, Philip M.
Roberts, Clive J.
Rose, Felicity R. A. J.
Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium
title Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium
title_full Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium
title_fullStr Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium
title_full_unstemmed Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium
title_short Nanofibrous Scaffolds Support a 3D in vitro Permeability Model of the Human Intestinal Epithelium
title_sort nanofibrous scaffolds support a 3d in vitro permeability model of the human intestinal epithelium
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524416/
https://www.ncbi.nlm.nih.gov/pubmed/31133850
http://dx.doi.org/10.3389/fphar.2019.00456
work_keys_str_mv AT patientjamied nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium
AT hajialihadi nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium
AT harriskate nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium
AT abrahamssonbertil nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium
AT tannergrenchrister nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium
AT whitelisaj nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium
AT ghaemmaghamiamirm nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium
AT williamsphilipm nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium
AT robertsclivej nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium
AT rosefelicityraj nanofibrousscaffoldssupporta3dinvitropermeabilitymodelofthehumanintestinalepithelium